Bottlenecks to clinical translation of direct brain-computer interfaces.
Publication/Presentation Date
1-1-2014
Abstract
Despite several decades of research into novel brain-implantable devices to treat a range of diseases, only two-cochlear implants for sensorineural hearing loss and deep brain stimulation for movement disorders-have yielded any appreciable clinical benefit. Obstacles to translation include technical factors (e.g., signal loss due to gliosis or micromotion), lack of awareness of current clinical options for patients that the new therapy must outperform, traversing between federal and corporate funding needed to support clinical trials, and insufficient management expertise. This commentary reviews these obstacles preventing the translation of promising new neurotechnologies into clinical application and suggests some principles that interdisciplinary teams in academia and industry could adopt to enhance their chances of success.
Volume
8
First Page
226
Last Page
226
ISSN
1662-5137
Published In/Presented At
Serruya M. D. (2014). Bottlenecks to clinical translation of direct brain-computer interfaces. Frontiers in systems neuroscience, 8, 226. https://doi.org/10.3389/fnsys.2014.00226
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
25520632
Department(s)
Administration and Leadership
Document Type
Article